Browse > Article
http://dx.doi.org/10.3904/kjim.2012.27.3.342

A Case of Severe Coronary Spasm Associated with 5-Fluorouracil Chemotherapy  

Kim, Sang-Min (Department of Internal Medicine, Cardiovascular Center, Inje University Seoul Paik Hospital)
Kwak, Cheol-Hoon (Department of Internal Medicine, Cardiovascular Center, Inje University Seoul Paik Hospital)
Lee, Bo-Ra (Department of Internal Medicine, Cardiovascular Center, Inje University Seoul Paik Hospital)
Kim, Seong-Beom (Department of Internal Medicine, Cardiovascular Center, Inje University Seoul Paik Hospital)
Sir, Jung-Ju (Department of Internal Medicine, Cardiovascular Center, National Medical Center)
Cho, Wook-Hyun (Department of Internal Medicine, Cardiovascular Center, Inje University Seoul Paik Hospital)
Choi, Suk-Koo (Department of Internal Medicine, Cardiovascular Center, Inje University Seoul Paik Hospital)
Publication Information
The Korean journal of internal medicine / v.27, no.3, 2012 , pp. 342-345 More about this Journal
Abstract
Cardiotoxicity associated with 5-fluorouracil (FU) is an uncommon, but potentially lethal, condition. The case of an 83-year-old man with colon cancer who developed chest pain during 5-FU infusion is presented. The electrocardiogram (ECG) showed pronounced ST elevation in the lateral leads, and the chest pain was resolved after infusion of nitroglycerin. A coronary angiogram (CAG) revealed that the patient had significant atherosclerosis in the proximal left circumflex artery. Coronary artery spasm with fixed stenosis was considered, and a drug-eluting stent was implanted. After 8 hours, the patient complained of recurring chest pain, paralleled by ST elevation on the ECG. The chest pain subsided after administration of intravenous nitroglycerin followed by sublingual nifedipine. Repeated CAG showed patency of the previous stent. This case supports the vasospastic hypothesis of 5-FU cardiac toxicity, indicating that a calcium channel blocker may be effective in the prevention or treatment of 5-FU cardiotoxicity.
Keywords
Fluorouracil; Coronary vasospasm; Calcium channel blockers; Angina pectoris;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Jensen SA, Sorensen JB. Risk factors and prevention of cardiotoxicity induced by 5-fluorouracil or capecitabine. Cancer Chemother Pharmacol 2006;58:487-493.   DOI   ScienceOn
2 Wacker A, Lersch C, Scherpinski U, Reindl L, Seyfarth M. High incidence of angina pectoris in patients treated with 5-fluorouracil: a planned surveillance study with 102 patients. Oncology 2003;65:108-112.   DOI   ScienceOn
3 Robben NC, P ippa s AW, Moore JO. The sy nd rome of 5-fluorouracil cardiotoxicity: an elusive cardiopathy. Cancer 1993;71:493-509.   DOI   ScienceOn
4 Kuzel T, Esparaz B, Green D, Kies M. Thrombogenicity of intravenous 5-f luorouracil alone or in combination with cisplatin. Cancer 1990;65:885-889.   DOI   ScienceOn
5 Gradishar WJ, Vokes EE. 5-Fluorouracil cardiotoxicity: a critical review. Ann Oncol 1990;1:409-414.   DOI
6 Rezkalla S, Kloner RA, Ensley J, et al. Continuous ambulatory ECG monitoring during fluorouracil therapy: a prospective study. J Clin Oncol 1989;7:509-514.   DOI
7 Kleiman NS, Lehane DE, Geyer CE Jr, Pratt CM, Young JB. Prinzmetal's angina during 5-fluorouracil chemotherapy. Am J Med 1987;82:566-568.   DOI   ScienceOn
8 Patel B, Kloner RA, Ensley J, Al-Sarraf M, Kish J, Wynne J. 5-fluorouracil cardiotoxicity: left ventricular dysfunction and effect of coronary vasodilators. Am J Med Sci 1987;294:238-243.   DOI   ScienceOn
9 Baker WP, Dainer P, Lester WM, Marty AM, Blair TP. Ischemic chest pain after 5-fluorouracil therapy for cancer. Am J Cardiol 1986;57:497-498.   DOI   ScienceOn
10 Meydan N, Kundak I, Yavuzsen T, et al. Cardiotoxicity of de Gramont's regimen: incidence, clinical characteristics and longterm follow-up. Jpn J Clin Oncol 2005;35:265-270.   DOI   ScienceOn